Curtis Coughlin II

About the Lab

Dr. Curtis Coughlin leads the research laboratory at the University of Colorado Anschutz. He completed his doctoral training with Dr. Stephen Goodman, and fondly remembers coffee fueled discussions about GA1 with Drs. Goodman and Woontner. He has been fortunate to have several excellent mentors throughout his career. He prioritizes team-science and has worked with many amazing colleagues such as Professor Sidney Gospe Jr and Clara van Karnebeek who continue to teach him about pyridoxine-dependent epilepsy.

Leadership & Mentorship

Dr. Coughlin has mentored several learners including individuals in master degree and PhD programs, medical students and residents, and junior faculty members. He has completed several formal mentoring programs and is committed to fostering an inclusive and collaborative research environment where all team members can thrive.

Alt text

Pyridoxine-dependent epilepsy: Diagnosis, new therapies, and potential newborn screening featured image

Pyridoxine-dependent epilepsy: Diagnosis, new therapies, and potential newborn screening

Dr. Coughlin discussed PDE-ALDH7A1 the XIII Congress for SLEIMPN

avatar
Curtis Coughlin II
Dietary management for pyridoxine-dependent epilepsy featured image

Dietary management for pyridoxine-dependent epilepsy

Dr. Coughlin joins members of the PDE Consoritum to discuss PDE-ALDH7A1.

avatar
Curtis Coughlin II
CRISPR Panel discussion featured image

CRISPR Panel discussion

Dr. Coughlin joins a panel to dicuss ethical issues and CRISPR

avatar
Curtis Coughlin II
Newborn screening for pyridoxine-dependent epilepsy featured image

Newborn screening for pyridoxine-dependent epilepsy

Dr. Coughlin discusses newborn screening and PDE-ALDH7A1.

avatar
Curtis Coughlin II
Ethical Considerations for Returning Clinical Genomic Results from a Population Biobank featured image

Ethical Considerations for Returning Clinical Genomic Results from a Population Biobank

Dr. Coughlin joins a panel dicussion on Biobanks and return of results.

avatar
Curtis Coughlin II
Pyridoxine Dependent Epilepsy (PDE): Overview, New Treatments, and the potential for Newborn Screening featured image

Pyridoxine Dependent Epilepsy (PDE): Overview, New Treatments, and the potential for Newborn Screening

This lecture highlights therapeutic advances for this rare but treatable disorder

avatar
Curtis Coughlin II
The time has come for newborn screening for pyridoxine-dependent epilepsy featured image

The time has come for newborn screening for pyridoxine-dependent epilepsy

his lecture will focus on the impact of neonatal treatment and developmental outcomes and new biomarkers for PDE-ALDH7A1.

avatar
Curtis Coughlin II